Human epidermal growth factor receptor 2 (HER2/ErbB2) is a member of the epidermal growth factor receptor family, and HER2-positive (HER2+) breast cancer accounts for approximately 20% of the histological types of breast cancer with a poor prognosis [2]. This evidence concerns the gene ERBB2 and breast carcinoma.